Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206908 · ClinicalTrials.gov registry record
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 900
- Enrollment target
NCT00206908 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 900 participants.
The verdict
NCT00206908 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
Study Summary
This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentration of various analytes present in EDTA-anticoagulated whole blood or plasma, specifically B-type natriuretic peptide (BNP), fibrin degradation products containing D-Dimer, matrix metalloproteiase-9 (MMP-9), and S-100B. The test utilizes a proprietary algorithm for the automatic calculation of a single Multimarker Index (MMX) result from the individual biomarker values. The MMX result is being evaluated for use as an aid in the assessment and diagnosis of stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2002-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00206908
The ClinicalTrials.gov registry entry for NCT00206908 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00206908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00206908 about?
NCT00206908 is a clinical study titled "BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)". This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentrati...
What is the current status of trial NCT00206908?
This trial is currently completed. The enrollment target is 900 participants. The study started on 2002-07.
Who is sponsoring clinical trial NCT00206908?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.